ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Search Committee Finishes Job, Submits Choices To Califano

April 15, 1977

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005

Cooperative Groups: Committee Formed To Implement Armitage Report Had A Rough Start

June 12, 1998

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997